Next Generation Antibody Market Scope And Analysis

  • Report Code : TIPRE00006412
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 181
Buy Now

Next-Generation Antibody Market Outlook and Scope 2031

Buy Now

Next-Generation Antibody Market Report Next-Generation Antibody Market Size and Share Next-Generation Antibody Market Scope and Analysis

Next-Generation Antibody Market Report Scope

Report Attribute Details
Market size in 2021 US$ 5.47 Billion
Market Size by 2028 US$ 12.05 Billion
Global CAGR (2021 - 2028) 11.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Therapeutic Area
  • Oncology and Autoimmune or Inflammatory
By Technology
  • Antibody-Drug Conjugates
  • Bispecific Antibodies
  • Fc Engineered Antibodies
  • Antibody Fragments and Antibody-Like Proteins
  • Biosimilar Antibody Products
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • F HOFFMANN LA ROCHE LTD
  • Kyowa Kirin Co Ltd
  • Seagen Inc
  • ImmunoGen Inc
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc
  • Pfizer Inc
  • Catalent Inc
  • AstraZeneca

    •  

    Company Profiles

    • F. HOFFMANN-LA ROCHE LTD.      
    • Kyowa Kirin Co., Ltd.                 
    • Seagen Inc.                             
    • ImmunoGen, Inc.                     
    • Takeda Pharmaceutical Company Limited  
    • Amgen Inc.                             
    • Pfizer Inc.                               
    • Catalent Inc                             
    • AstraZeneca                            
    • Xencor